BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 182658)

  • 21. Antigen-independent expansion of T cells from psoriatic skin lesions: phenotypic characterization and antigen reactivity.
    Horrocks C; Holder JE; Berth-Jones J; Camp RD
    Br J Dermatol; 1997 Sep; 137(3):331-8. PubMed ID: 9349325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neutrophil chemotaxis in psoriasis.
    Wahba A; Cohen H; Bar-Eli M; Callily R
    Acta Derm Venereol; 1979; 59(5):441-5. PubMed ID: 93368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A combination of psoriasis vulgaris and nevus cell nevus--clinical, histopathologic and histochemical findings].
    Wollina U; Schaarschmidt H; Henkel U; Roth H; Barta U; Hipler C
    Z Hautkr; 1990 Apr; 65(4):381-2, 385-7. PubMed ID: 2195791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distribution of dipeptidyl-peptidase IV on keratinocytes in the margin zone of a psoriatic lesion: a comparison with hyperproliferation and aberrant differentiation markers.
    van Lingen RG; Poll MK; Seyger MM; de Jong EM; van de Kerkhof PC; van Erp PE
    Arch Dermatol Res; 2008 Nov; 300(10):561-7. PubMed ID: 18496701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation.
    Bovenschen HJ; Seyger MM; Van de Kerkhof PC
    Br J Dermatol; 2005 Jul; 153(1):72-8. PubMed ID: 16029329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphocyte cyclic nucleotide and prostaglandin content in psoriasis: a preliminary report.
    Harpaz S; Fink A; Zuckerman F; Muhammad E
    Arch Dermatol; 1980 Apr; 116(4):427-8. PubMed ID: 6245622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcitonin gene-related peptide in Langerhans cells in psoriatic plaque lesions.
    He Y; Ding G; Wang X; Zhu T; Fan S
    Chin Med J (Engl); 2000 Aug; 113(8):747-51. PubMed ID: 11776062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of corticotropin-releasing hormone and receptor in the pathogenesis of psoriasis.
    Zhou C; Yu X; Cai D; Liu C; Li C
    Med Hypotheses; 2009 Oct; 73(4):513-5. PubMed ID: 19560286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum and tissue expression of transforming growth factor beta 1 in psoriasis.
    Zaher H; Shaker OG; EL-Komy MH; El-Tawdi A; Fawzi M; Kadry D
    J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):406-9. PubMed ID: 19175705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclic AMP and psoriasis once more.
    Wadskov S; Kassis V; Søndergaard J
    Acta Derm Venereol; 1979; 59(6):525-7. PubMed ID: 94212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Behavior of papillary capillaries in initial common psoriasis].
    Schlosser W; Pullmann H
    Z Hautkr; 1978 Oct; 53(20):737-9. PubMed ID: 716523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psoriasis as a possible defect of the adenyl cyclase-cyclic AMP cascade. A defective chalone mechanism?
    Voorhees JJ; Duell EA
    Arch Dermatol; 1971 Oct; 104(4):352-8. PubMed ID: 4329804
    [No Abstract]   [Full Text] [Related]  

  • 33. E-selectin and vascular cell adhesion molecule-1 are critical for initial trafficking of helper-inducer/memory T cells in psoriatic plaques.
    Wakita H; Takigawa M
    Arch Dermatol; 1994 Apr; 130(4):457-63. PubMed ID: 7513146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Memory effector (CD45RO+) and cytotoxic (CD8+) T cells appear early in the margin zone of spreading psoriatic lesions in contrast to cells expressing natural killer receptors, which appear late.
    Vissers WH; Arndtz CH; Muys L; Van Erp PE; de Jong EM; van de Kerkhof PC
    Br J Dermatol; 2004 May; 150(5):852-9. PubMed ID: 15149496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
    Yoshida A; Kanno H; Watabe D; Akasaka T; Sawai T
    Arch Dermatol Res; 2008 Jan; 300(1):37-45. PubMed ID: 17960400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential T-cell reactivity to the round and oval forms of Pityrosporum in the skin of patients with psoriasis.
    Baker BS; Powles A; Garioch JJ; Hardman C; Fry L
    Br J Dermatol; 1997 Mar; 136(3):319-25. PubMed ID: 9115908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for an antigen-specific cellular immune response in skin lesions of patients with psoriasis vulgaris.
    Menssen A; Trommler P; Vollmer S; Schendel D; Albert E; Gürtler L; Riethmüller G; Prinz JC
    J Immunol; 1995 Oct; 155(8):4078-83. PubMed ID: 7561119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidermal cyclic AMP is not decreased in psoriasis lesions.
    Adachi K; Iizuka H; Halprin KM; Levine V
    J Invest Dermatol; 1980 Feb; 74(2):74-6. PubMed ID: 6243335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Present knowledge on the pathogenesis of common psoriasis as the basis for a scientifically founded therapy. I. Pathogenesis of common psoriasis].
    Sönnichsen N; Haustein UF; Kluge K; Meffert H
    Dtsch Gesundheitsw; 1970 Jul; 25(27):1245-8. PubMed ID: 4929453
    [No Abstract]   [Full Text] [Related]  

  • 40. [Pathogenesis of psoriasis in the light of current theories on the regulation of mitosis of epithelial cells].
    Frolov EP; Dunaeva LP; Shatilova NV; Mordovtsev VN
    Vestn Dermatol Venerol; 1978 Jul; (7):52-8. PubMed ID: 211749
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.